BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luangmonkong T, Suriguga S, Mutsaers HAM, Groothuis GMM, Olinga P, Boersema M. Targeting Oxidative Stress for the Treatment of Liver Fibrosis. Rev Physiol Biochem Pharmacol. 2018;175:71-102. [PMID: 29728869 DOI: 10.1007/112_2018_10] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 17.3] [Reference Citation Analysis]
Number Citing Articles
1 Foglia B, Novo E, Protopapa F, Maggiora M, Bocca C, Cannito S, Parola M. Hypoxia, Hypoxia-Inducible Factors and Liver Fibrosis. Cells 2021;10:1764. [PMID: 34359934 DOI: 10.3390/cells10071764] [Reference Citation Analysis]
2 Baglieri J, Brenner DA, Kisseleva T. The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma. Int J Mol Sci 2019;20:E1723. [PMID: 30959975 DOI: 10.3390/ijms20071723] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Portincasa P, Bonfrate L, Khalil M, Angelis MD, Calabrese FM, D’amato M, Wang DQ, Di Ciaula A. Intestinal Barrier and Permeability in Health, Obesity and NAFLD. Biomedicines 2022;10:83. [DOI: 10.3390/biomedicines10010083] [Reference Citation Analysis]
4 Shi L, Zhang X, Liu X, Jiang Y, Deng Y, Liu J. Cranberry (Vacinium macrocarpon) phytochemicals inhibit hepatic stellate cell activation and liver fibrosis. Food Bioscience 2021;42:101176. [DOI: 10.1016/j.fbio.2021.101176] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Bai Y, Wang W, Wang L, Ma L, Zhai D, Wang F, Shi R, Liu C, Xu Q, Chen G, Lu Z. Obacunone Attenuates Liver Fibrosis with Enhancing Anti-Oxidant Effects of GPx-4 and Inhibition of EMT. Molecules 2021;26:E318. [PMID: 33435504 DOI: 10.3390/molecules26020318] [Reference Citation Analysis]
6 Khomich O, Ivanov AV, Bartosch B. Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis. Cells 2019;9:E24. [PMID: 31861818 DOI: 10.3390/cells9010024] [Cited by in Crossref: 28] [Cited by in F6Publishing: 35] [Article Influence: 9.3] [Reference Citation Analysis]
7 Kim JY, Choi Y, Leem J, Song JE. Heme Oxygenase-1 Induction by Cobalt Protoporphyrin Ameliorates Cholestatic Liver Disease in a Xenobiotic-Induced Murine Model. Int J Mol Sci 2021;22:8253. [PMID: 34361019 DOI: 10.3390/ijms22158253] [Reference Citation Analysis]
8 Hurtado-Carneiro V, Dongil P, Pérez-García A, Álvarez E, Sanz C. Preventing Oxidative Stress in the Liver: An Opportunity for GLP-1 and/or PASK. Antioxidants (Basel) 2021;10:2028. [PMID: 34943132 DOI: 10.3390/antiox10122028] [Reference Citation Analysis]
9 Seo HY, Lee SH, Lee JH, Hwang JS, Kim MK, Jang BK. Kahweol activates the Nrf2/HO-1 pathway by decreasing Keap1 expression independently of p62 and autophagy pathways. PLoS One 2020;15:e0240478. [PMID: 33044988 DOI: 10.1371/journal.pone.0240478] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Anticoli S, Amatore D, Matarrese P, De Angelis M, Palamara AT, Nencioni L, Ruggieri A. Counteraction of HCV-Induced Oxidative Stress Concurs to Establish Chronic Infection in Liver Cell Cultures. Oxid Med Cell Longev 2019;2019:6452390. [PMID: 30906503 DOI: 10.1155/2019/6452390] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
11 Novo E, Bocca C, Foglia B, Protopapa F, Maggiora M, Parola M, Cannito S. Liver fibrogenesis: un update on established and emerging basic concepts. Arch Biochem Biophys 2020;689:108445. [PMID: 32524998 DOI: 10.1016/j.abb.2020.108445] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
12 Dokumacioğlu E, Iskender H, Terim Kapakin KA, Yenice G, Mokthare B, Bolat İ, Hayırlı A. Effect of betulinic acid administration on TLR-9/NF-κB /IL-18 levels in experimental liver injury. Turk J Med Sci 2021;51:1544-53. [PMID: 33773522 DOI: 10.3906/sag-2004-184] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Sun R, Tian X, Li Y, Zhao Y, Wang Z, Hu Y, Zhang L, Wang Y, Gao D, Zheng S, Yao J. The m6A reader YTHDF3-mediated PRDX3 translation alleviates liver fibrosis. Redox Biology 2022;54:102378. [DOI: 10.1016/j.redox.2022.102378] [Reference Citation Analysis]
14 Fan Y, Li Y, Chu Y, Liu J, Cui L, Zhang D. Toll-Like Receptors Recognize Intestinal Microbes in Liver Cirrhosis. Front Immunol 2021;12:608498. [PMID: 33708204 DOI: 10.3389/fimmu.2021.608498] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Pang Q, Jin H, Wang Y, Dai M, Liu S, Tan Y, Liu H, Lu Z. Depletion of serotonin relieves concanavalin A-induced liver fibrosis in mice by inhibiting inflammation, oxidative stress, and TGF-β1/Smads signaling pathway. Toxicol Lett 2021;340:123-32. [PMID: 33429011 DOI: 10.1016/j.toxlet.2021.01.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Nicoletti A, Ponziani FR, Biolato M, Valenza V, Marrone G, Sganga G, Gasbarrini A, Miele L, Grieco A. Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation. World J Gastroenterol 2019; 25(33): 4814-4834 [PMID: 31543676 DOI: 10.3748/wjg.v25.i33.4814] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 26] [Article Influence: 10.3] [Reference Citation Analysis]
17 Iskender H, Dokumacioglu E, Terim Kapakin KA, Yenice G, Mohtare B, Bolat I, Hayirli A. Effects of oleanolic acid on inflammation and metabolism in diabetic rats. Biotech Histochem 2021;:1-8. [PMID: 34261397 DOI: 10.1080/10520295.2021.1954691] [Reference Citation Analysis]
18 Ceccherini E, Cecchettini A, Morales MA, Rocchiccioli S. The Potentiality of Herbal Remedies in Primary Sclerosing Cholangitis: From In Vitro to Clinical Studies. Front Pharmacol 2020;11:813. [PMID: 32587513 DOI: 10.3389/fphar.2020.00813] [Reference Citation Analysis]
19 Chen Z, Tian R, She Z, Cai J, Li H. Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. Free Radic Biol Med 2020;152:116-41. [PMID: 32156524 DOI: 10.1016/j.freeradbiomed.2020.02.025] [Cited by in Crossref: 90] [Cited by in F6Publishing: 82] [Article Influence: 45.0] [Reference Citation Analysis]
20 Zheng WV, Li Y, Cheng X, Xu Y, Zhou T, Li D, Xiong Y, Wang S, Chen Z. Uridine alleviates carbon tetrachloride-induced liver fibrosis by regulating the activity of liver-related cells. J Cell Mol Med 2021. [PMID: 34970843 DOI: 10.1111/jcmm.17131] [Reference Citation Analysis]
21 Di Ciaula A, Passarella S, Shanmugam H, Noviello M, Bonfrate L, Wang DQ, Portincasa P. Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies? Int J Mol Sci 2021;22:5375. [PMID: 34065331 DOI: 10.3390/ijms22105375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Zhou M, Zhao X, Liao L, Deng Y, Liu M, Wang J, Xue X, Li Y. Forsythiaside A Regulates Activation of Hepatic Stellate Cells by Inhibiting NOX4-Dependent ROS. Oxid Med Cell Longev 2022;2022:9938392. [PMID: 35035671 DOI: 10.1155/2022/9938392] [Reference Citation Analysis]
23 Yu Y, Wang J, Wang X, Gu P, Lei Z, Tang R, Wei C, Xu L, Wang C, Chen Y, Pu Y, Qi X, Yu B, Chen X, Zhu J, Li Y, Zhang Z, Zhou S, Su C. Schistosome eggs stimulate reactive oxygen species production to enhance M2 macrophage differentiation and promote hepatic pathology in schistosomiasis. PLoS Negl Trop Dis 2021;15:e0009696. [PMID: 34398890 DOI: 10.1371/journal.pntd.0009696] [Reference Citation Analysis]
24 Liu ZJ, Yan YJ, Weng HL, Ding HG. Type 2 diabetes mellitus increases liver transplant-free mortality in patients with cirrhosis: A systematic review and meta-analysis. World J Clin Cases 2021; 9(20): 5514-5525 [PMID: 34307604 DOI: 10.12998/wjcc.v9.i20.5514] [Reference Citation Analysis]
25 Chen Y, Yuan S, Cao Y, Kong G, Jiang F, Li Y, Wang Q, Tang M, Zhang Q, Wang Q, Liu L. Gasotransmitters: Potential Therapeutic Molecules of Fibrotic Diseases. Oxid Med Cell Longev 2021;2021:3206982. [PMID: 34594474 DOI: 10.1155/2021/3206982] [Reference Citation Analysis]
26 Peng W, Xu S, Zhang J, Zhang Y. Vitamin C Attenuates Sodium Fluoride-Induced Mitochondrial Oxidative Stress and Apoptosis via Sirt1-SOD2 Pathway in F9 Cells. Biol Trace Elem Res 2019;191:189-98. [PMID: 30565018 DOI: 10.1007/s12011-018-1599-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
27 Piñeiro-ramil M, Flórez-fernández N, Ramil-gómez O, Torres MD, Dominguez H, Blanco FJ, Meijide-faílde R, Vaamonde-garcía C. Antifibrotic effect of brown algae-derived fucoidans on osteoarthritic fibroblast-like synoviocytes. Carbohydrate Polymers 2022;282:119134. [DOI: 10.1016/j.carbpol.2022.119134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Gong Y, Yang Y. Activation of Nrf2/AREs-mediated antioxidant signalling, and suppression of profibrotic TGF-β1/Smad3 pathway: a promising therapeutic strategy for hepatic fibrosis - A review. Life Sci 2020;256:117909. [PMID: 32512009 DOI: 10.1016/j.lfs.2020.117909] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
29 Uchida D, Takaki A, Oyama A, Adachi T, Wada N, Onishi H, Okada H. Oxidative Stress Management in Chronic Liver Diseases and Hepatocellular Carcinoma. Nutrients 2020;12:E1576. [PMID: 32481552 DOI: 10.3390/nu12061576] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
30 Dhar D, Baglieri J, Kisseleva T, Brenner DA. Mechanisms of liver fibrosis and its role in liver cancer. Exp Biol Med (Maywood) 2020;245:96-108. [PMID: 31924111 DOI: 10.1177/1535370219898141] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
31 Diao Y, Hu D, Hu X, Wang P, Wang X, Luo X, Wang H, Ning Q. The Role of Metabolic Factors and Steatosis in Treatment-Naïve Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase. Infect Dis Ther. [DOI: 10.1007/s40121-022-00629-5] [Reference Citation Analysis]
32 Berumen J, Baglieri J, Kisseleva T, Mekeel K. Liver fibrosis: Pathophysiology and clinical implications. Wiley Interdiscip Rev Syst Biol Med. 2020;e1499. [PMID: 32713091 DOI: 10.1002/wsbm.1499] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
33 Kwon HC, Sohn H, Kim DH, Shin DM, Jeong CH, Chang YH, Yune JH, Kim YJ, Kim DW, Kim SH, Han SG. In Vitro and In Vivo Study on the Toxic Effects of Propiconazole Fungicide in the Pathogenesis of Liver Fibrosis. J Agric Food Chem 2021;69:7399-408. [PMID: 34170130 DOI: 10.1021/acs.jafc.1c01086] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Mousavi K, Niknahad H, Li H, Jia Z, Manthari RK, Zhao Y, Shi X, Chen Y, Ahmadi A, Azarpira N, Khalvati B, Ommati MM, Heidari R. The activation of nuclear factor-E2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) signaling blunts cholestasis-induced liver and kidney injury. Toxicol Res (Camb) 2021;10:911-27. [PMID: 34484683 DOI: 10.1093/toxres/tfab073] [Reference Citation Analysis]
35 George J, Tsuchishima M, Tsutsumi M. Metabolism of N-nitrosodimethylamine, methylation of macromolecules, and development of hepatic fibrosis in rodent models. J Mol Med (Berl) 2020;98:1203-13. [PMID: 32666246 DOI: 10.1007/s00109-020-01950-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Wang JH, Lee SB, Lee DS, Son CG. Total Antioxidant Capacity in HBV Carriers, a Promising Biomarker for Evaluating Hepatic Fibrosis: A Pilot Study. Antioxidants (Basel) 2021;10:77. [PMID: 33435626 DOI: 10.3390/antiox10010077] [Reference Citation Analysis]
37 George J, Tsuchishima M, Tsutsumi M. Molecular mechanisms in the pathogenesis of N-nitrosodimethylamine induced hepatic fibrosis. Cell Death Dis 2019;10:18. [PMID: 30622238 DOI: 10.1038/s41419-018-1272-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
38 Parola M, Pinzani M. Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med. 2019;65:37-55. [PMID: 30213667 DOI: 10.1016/j.mam.2018.09.002] [Cited by in Crossref: 121] [Cited by in F6Publishing: 127] [Article Influence: 30.3] [Reference Citation Analysis]
39 Wu TH, Wang PW, Lin TY, Yang PM, Li WT, Yeh CT, Pan TL. Antioxidant properties of red raspberry extract alleviate hepatic fibrosis via inducing apoptosis and transdifferentiation of activated hepatic stellate cells. Biomed Pharmacother 2021;144:112284. [PMID: 34626932 DOI: 10.1016/j.biopha.2021.112284] [Reference Citation Analysis]
40 Li YJ, Liu RP, Ding MN, Zheng Q, Wu JZ, Xue XY, Gu YQ, Ma BN, Cai YJ, Li S, Lin S, Zhang LY, Li X. Tetramethylpyrazine prevents liver fibrotic injury in mice by targeting hepatocyte-derived and mitochondrial DNA-enriched extracellular vesicles. Acta Pharmacol Sin 2022. [PMID: 35027662 DOI: 10.1038/s41401-021-00843-w] [Reference Citation Analysis]
41 Di Ciaula A, Baj J, Garruti G, Celano G, De Angelis M, Wang HH, Di Palo DM, Bonfrate L, Wang DQ, Portincasa P. Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk. J Clin Med 2020;9:E2648. [PMID: 32823983 DOI: 10.3390/jcm9082648] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
42 Ge C, Tan J, Lou D, Zhu L, Zhong Z, Dai X, Sun Y, Kuang Q, Zhao J, Wang L, Liu J, Wang B, Xu M. Mulberrin confers protection against hepatic fibrosis by Trim31/Nrf2 signaling. Redox Biology 2022;51:102274. [DOI: 10.1016/j.redox.2022.102274] [Reference Citation Analysis]
43 Aydin M, Dirik Y, Demir C, Tolunay HE, Demir H. Can we reduce oxidative stress with liver transplantation? J Med Biochem 2021;40:351-7. [PMID: 34616224 DOI: 10.5937/jomb0-29983] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Han X, Wu Y, Yang Q, Cao G. Peroxisome proliferator-activated receptors in the pathogenesis and therapies of liver fibrosis. Pharmacol Ther 2021;222:107791. [PMID: 33321113 DOI: 10.1016/j.pharmthera.2020.107791] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
45 Virzì A, Roca Suarez AA, Baumert TF, Lupberger J. Rewiring Host Signaling: Hepatitis C Virus in Liver Pathogenesis. Cold Spring Harb Perspect Med 2020;10:a037366. [PMID: 31501266 DOI: 10.1101/cshperspect.a037366] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
46 Sun Y, Pan H, Shen S, Xia Z, Yu Z, Li C, Sun P, Xin C. Alisma Shugan Decoction (ASD) Ameliorates Hepatotoxicity and Associated Liver Dysfunction by Inhibiting Oxidative Stress and p65/Nrf2/JunD Signaling Dysregulation In Vivo. Med Sci Monit 2020;26:e921738. [PMID: 32672153 DOI: 10.12659/MSM.921738] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Wu L, Xu W, Li H, Dong B, Geng H, Jin J, Han D, Liu H, Zhu X, Yang Y, Xie S. Vitamin C Attenuates Oxidative Stress, Inflammation, and Apoptosis Induced by Acute Hypoxia through the Nrf2/Keap1 Signaling Pathway in Gibel Carp (Carassius gibelio). Antioxidants 2022;11:935. [DOI: 10.3390/antiox11050935] [Reference Citation Analysis]
48 Foglia B, Cannito S, Bocca C, Parola M, Novo E. ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis. Int J Mol Sci. 2019;20. [PMID: 31159366 DOI: 10.3390/ijms20112700] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
49 Hao W, Li M, Cai Q, Wu S, Li X, He Q, Hu Y. Roles of NRF2 in Fibrotic Diseases: From Mechanisms to Therapeutic Approaches. Front Physiol 2022;13:889792. [DOI: 10.3389/fphys.2022.889792] [Reference Citation Analysis]
50 Li Y, Zhang D, Li L, Han Y, Dong X, Yang L, Li X, Li W, Li W. Ginsenoside Rg1 ameliorates aging‑induced liver fibrosis by inhibiting the NOX4/NLRP3 inflammasome in SAMP8 mice. Mol Med Rep 2021;24:801. [PMID: 34523690 DOI: 10.3892/mmr.2021.12441] [Reference Citation Analysis]
51 Ommati MM, Attari H, Siavashpour A, Shafaghat M, Azarpira N, Ghaffari H, Moezi L, Heidari R. Mitigation of cholestasis-associated hepatic and renal injury by edaravone treatment: Evaluation of its effects on oxidative stress and mitochondrial function. Liver Research 2021;5:181-93. [DOI: 10.1016/j.livres.2020.10.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
52 Soleimani D, Rezaie M, Rajabzadeh F, Gholizadeh Navashenaq J, Abbaspour M, Miryan M, Razmpour F, Ranjbar G, Rezvani R, Jarahi L, Hashemy SI, Goshayeshi L, Nematy M. Protective effects of propolis on hepatic steatosis and fibrosis among patients with nonalcoholic fatty liver disease (NAFLD) evaluated by real-time two-dimensional shear wave elastography: A randomized clinical trial. Phytother Res 2021;35:1669-79. [PMID: 33166032 DOI: 10.1002/ptr.6937] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
53 Zhou L, Li Y, Liang Q, Liu J, Liu Y. Combination therapy based on targeted nano drug co-delivery systems for liver fibrosis treatment: A review. J Drug Target 2022;:1-22. [PMID: 35179094 DOI: 10.1080/1061186X.2022.2044485] [Reference Citation Analysis]
54 Scudiero O, Pero R, Ranieri A, Terracciano D, Fimiani F, Cesaro A, Gentile L, Leggiero E, Laneri S, Moscarella E, Mazzaccara C, Frisso G, D'Alicandro G, Limongelli G, Pastore L, Calabrò P, Lombardo B. Childhood obesity: an overview of laboratory medicine, exercise and microbiome. Clin Chem Lab Med 2020;58:1385-406. [PMID: 31821163 DOI: 10.1515/cclm-2019-0789] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
55 Mooli RGR, Mukhi D, Ramakrishnan SK. Oxidative Stress and Redox Signaling in the Pathophysiology of Liver Diseases. Compr Physiol 2022;12:3167-92. [PMID: 35578969 DOI: 10.1002/cphy.c200021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Grattagliano I, Di Ciaula A, Baj J, Molina-Molina E, Shanmugam H, Garruti G, Wang DQ, Portincasa P. Protocols for Mitochondria as the Target of Pharmacological Therapy in the Context of Nonalcoholic Fatty Liver Disease (NAFLD). Methods Mol Biol 2021;2310:201-46. [PMID: 34096005 DOI: 10.1007/978-1-0716-1433-4_12] [Reference Citation Analysis]
57 Sadasivam N, Kim Y, Radhakrishnan K, Kim D. Oxidative Stress, Genomic Integrity, and Liver Diseases. Molecules 2022;27:3159. [DOI: 10.3390/molecules27103159] [Reference Citation Analysis]
58 Hao J, Ding Y, Shi W, Zhang C, Li R. Functional Food XingJiuTang Attenuates Alcohol-Induced Liver Injury by Regulating SIRT1/Nrf-2 Signaling Pathway. Chem Biodivers 2020;17:e2000619. [PMID: 33084229 DOI: 10.1002/cbdv.202000619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
59 Levada K, Omelyanchik A, Rodionova V, Weiskirchen R, Bartneck M. Magnetic-Assisted Treatment of Liver Fibrosis. Cells 2019;8:E1279. [PMID: 31635053 DOI: 10.3390/cells8101279] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
60 Li Y, Li Y, Fang Z, Huang D, Yang Y, Zhao D, Hang M, Wang J. The effect of Malus doumeri leaf flavonoids on oxidative stress injury induced by hydrogen peroxide (H2O2) in human embryonic kidney 293 T cells. BMC Complement Med Ther 2020;20:276. [PMID: 32917204 DOI: 10.1186/s12906-020-03072-6] [Reference Citation Analysis]
61 Zhang Q, Luo P, Zheng L, Chen J, Zhang J, Tang H, Liu D, He X, Shi Q, Gu L, Li J, Guo Q, Yang C, Wong YK, Xia F, Wang J. 18beta-Glycyrrhetinic acid induces ROS-mediated apoptosis to ameliorate hepatic fibrosis by targeting PRDX1/2 in activated HSCs. Journal of Pharmaceutical Analysis 2022. [DOI: 10.1016/j.jpha.2022.06.001] [Reference Citation Analysis]
62 Udayawara Rudresh D, Maradagi T, Stephen NM, Niraikulam A, Nambi Ramudu K, Ponesakki G. Neoxanthin prevents H2O2-induced cytotoxicity in HepG2 cells by activating endogenous antioxidant signals and suppressing apoptosis signals. Mol Biol Rep 2021;48:6923-34. [PMID: 34487292 DOI: 10.1007/s11033-021-06695-1] [Reference Citation Analysis]
63 Finamor IA, Bressan CA, Torres-Cuevas I, Rius-Pérez S, da Veiga M, Rocha MI, Pavanato MA, Pérez S. Long-Term Aspartame Administration Leads to Fibrosis, Inflammasome Activation, and Gluconeogenesis Impairment in the Liver of Mice. Biology (Basel) 2021;10:82. [PMID: 33499218 DOI: 10.3390/biology10020082] [Reference Citation Analysis]
64 Miao H, Zhang Y, Huang Z, Lu B, Ji L. Lonicera japonica Attenuates Carbon Tetrachloride-Induced Liver Fibrosis in Mice: Molecular Mechanisms of Action. Am J Chin Med 2019;47:351-67. [PMID: 30871359 DOI: 10.1142/S0192415X19500174] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
65 Al-Ani B, Alzamil NM, Hewett PW, Al-Hashem F, Bin-Jaliah I, Shatoor AS, Kamar SS, Latif NSA, Haidara MA, Dawood AF. Metformin ameliorates ROS-p53-collagen axis of fibrosis and dyslipidemia in type 2 diabetes mellitus-induced left ventricular injury. Arch Physiol Biochem 2021;:1-7. [PMID: 33439743 DOI: 10.1080/13813455.2020.1869265] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
66 Dai C, Yusuf A, Sun H, Shu G, Deng X. A characterized saponin extract of Panax japonicus suppresses hepatocyte EMT and HSC activation in vitro and CCl4-provoked liver fibrosis in mice: Roles of its modulatory effects on the Akt/GSK3β/Nrf2 cascade. Phytomedicine 2021;93:153746. [PMID: 34634746 DOI: 10.1016/j.phymed.2021.153746] [Reference Citation Analysis]
67 He L, Guo C, Peng C, Li Y. Advances of natural activators for Nrf2 signaling pathway on cholestatic liver injury protection: a review. Eur J Pharmacol 2021;910:174447. [PMID: 34461126 DOI: 10.1016/j.ejphar.2021.174447] [Reference Citation Analysis]
68 Chang BY, Kim HJ, Kim TY, Kim SY. Enzyme-Treated Zizania latifolia Extract Protects against Alcohol-Induced Liver Injury by Regulating the NRF2 Pathway. Antioxidants (Basel) 2021;10:960. [PMID: 34203789 DOI: 10.3390/antiox10060960] [Reference Citation Analysis]
69 Shen M, Guo M, Wang Z, Li Y, Kong D, Shao J, Tan S, Chen A, Zhang F, Zhang Z, Zheng S. ROS-dependent inhibition of the PI3K/Akt/mTOR signaling is required for Oroxylin A to exert anti-inflammatory activity in liver fibrosis. Int Immunopharmacol 2020;85:106637. [PMID: 32512269 DOI: 10.1016/j.intimp.2020.106637] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
70 Zhang IW, López-Vicario C, Duran-Güell M, Clària J. Mitochondrial Dysfunction in Advanced Liver Disease: Emerging Concepts. Front Mol Biosci 2021;8:772174. [PMID: 34888354 DOI: 10.3389/fmolb.2021.772174] [Reference Citation Analysis]
71 Piera-Velazquez S, Jimenez SA. Oxidative Stress Induced by Reactive Oxygen Species (ROS) and NADPH Oxidase 4 (NOX4) in the Pathogenesis of the Fibrotic Process in Systemic Sclerosis: A Promising Therapeutic Target. J Clin Med 2021;10:4791. [PMID: 34682914 DOI: 10.3390/jcm10204791] [Reference Citation Analysis]
72 Zhao J, Liu X, Chen Y, Zhang LS, Zhang YR, Ji DR, Liu SM, Jia MZ, Zhu YH, Qi YF, Lu FM, Yu YR. STAT3 Promotes Schistosome-Induced Liver Injury by Inflammation, Oxidative Stress, Proliferation, and Apoptosis Signal Pathway. Infect Immun 2021;89:e00309-20. [PMID: 33257536 DOI: 10.1128/IAI.00309-20] [Reference Citation Analysis]
73 Zhang P, Yin Y, Wang T, Li W, Li C, Zeng X, Yang W, Zhang R, Tang Y, Shi L, Li R, Tao K. Maresin 1 mitigates concanavalin A-induced acute liver injury in mice by inhibiting ROS-mediated activation of NF-κB signaling. Free Radic Biol Med 2020;147:23-36. [PMID: 31785331 DOI: 10.1016/j.freeradbiomed.2019.11.033] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
74 Yeh CW, Wu WJ, Lu CW, Wang SE, Chuang WC, Lee MC, Wu CH. Traditional Chinese Medicine Yang-Gan-Wan Alleviated Experimental Hepatic Damage by Inhibiting Oxidation, Inflammation, and Apoptosis in Cell and Mouse Models. Evid Based Complement Alternat Med 2021;2021:2556352. [PMID: 34659428 DOI: 10.1155/2021/2556352] [Reference Citation Analysis]
75 Zhao ZB, Ji K, Shen XY, Zhang WW, Wang R, Xu WP, Wei W. Di(2-ethylhexyl) phthalate promotes hepatic fibrosis by regulation of oxidative stress and inflammation responses in rats. Environ Toxicol Pharmacol 2019;68:109-19. [PMID: 30884453 DOI: 10.1016/j.etap.2019.03.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
76 Ala M, Eftekhar SP. Target Sestrin2 to Rescue the Damaged Organ: Mechanistic Insight into Its Function. Oxid Med Cell Longev 2021;2021:8790369. [PMID: 34765085 DOI: 10.1155/2021/8790369] [Reference Citation Analysis]
77 Li S, Zheng X, Zhang X, Yu H, Han B, Lv Y, Liu Y, Wang X, Zhang Z. Exploring the liver fibrosis induced by deltamethrin exposure in quails and elucidating the protective mechanism of resveratrol. Ecotoxicol Environ Saf 2021;207:111501. [PMID: 33254389 DOI: 10.1016/j.ecoenv.2020.111501] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
78 Baglieri J, Brenner DA, Kisseleva T. The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma. Int J Mol Sci 2019;20:E1723. [PMID: 30959975 DOI: 10.3390/ijms20071723] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 19.7] [Reference Citation Analysis]
79 Feng Y, Li H, Chen C, Lin H, Xu G, Li H, Wang C, Chen J, Sun J. Study on the Hepatoprotection of Schisandra chinensis Caulis Polysaccharides in Nonalcoholic Fatty Liver Disease in Rats Based on Metabolomics. Front Pharmacol 2021;12:727636. [PMID: 34621168 DOI: 10.3389/fphar.2021.727636] [Reference Citation Analysis]
80 Leilei L, Wenke Q, Yuyuan L, Sihang L, Xue S, Weiqiang C, Lianbao Y, Ying W, Yan L, Ming L. Oleanolic acid-loaded nanoparticles attenuate activation of hepatic stellate cells via suppressing TGF-β1 and oxidative stress in PM2.5-exposed hepatocytes. Toxicol Appl Pharmacol 2022;:115891. [PMID: 35077758 DOI: 10.1016/j.taap.2022.115891] [Reference Citation Analysis]
81 Acharya P, Chouhan K, Weiskirchen S, Weiskirchen R. Cellular Mechanisms of Liver Fibrosis. Front Pharmacol 2021;12:671640. [PMID: 34025430 DOI: 10.3389/fphar.2021.671640] [Reference Citation Analysis]
82 Di Ciaula A, Calamita G, Shanmugam H, Khalil M, Bonfrate L, Wang DQ, Baffy G, Portincasa P. Mitochondria Matter: Systemic Aspects of Nonalcoholic Fatty Liver Disease (NAFLD) and Diagnostic Assessment of Liver Function by Stable Isotope Dynamic Breath Tests. Int J Mol Sci 2021;22:7702. [PMID: 34299321 DOI: 10.3390/ijms22147702] [Reference Citation Analysis]
83 Rodríguez MJ, Sabaj M, Tolosa G, Herrera Vielma F, Zúñiga MJ, González DR, Zúñiga-Hernández J. Maresin-1 Prevents Liver Fibrosis by Targeting Nrf2 and NF-κB, Reducing Oxidative Stress and Inflammation. Cells 2021;10:3406. [PMID: 34943914 DOI: 10.3390/cells10123406] [Reference Citation Analysis]